SCHEMBL8807343

SCHEMBL8807343

COc1ccc(CN(C)CCCc2ccc(NC(=O)c3cccc4c(=O)c5cc(F)ccc5sc34)cc2)cc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 3/20 0.42
▸ ABCG2 Q9UNQ0 3/20 0.42
▸ OPRK1 P41145 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ OPRM1 P35372 3/20 0.39
▸ TMEM97 Q5BJF2 3/20 0.39
▸ SIGMAR1 Q99720 3/20 0.39
▸ BCHE P06276 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ LTA4H P09960 1/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ NR1H4 Q96RI1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8806985 0.98 ABCB1 (0.42) ABCB1ABCG2OPRK1MAPK1SMN1; SMN2
SCHEMBL8806933 0.95 KDM4E (0.42) ABCB1ABCG2OPRK1MAPK1SMN1; SMN2
SCHEMBL8806058 0.92 ABCB1 (0.43) ABCB1ABCG2MAPK1TP53RXFP1
SCHEMBL8809632 0.92 BCHE (0.44) ABCB1ABCG2OPRK1MAPK1SMN1; SMN2
SCHEMBL8807354 0.90 ABCG2 (0.40) ABCB1ABCG2MAPK1SMN1; SMN2MEN1
SCHEMBL8807273 0.90 ABCB1 (0.46) ABCB1ABCG2OPRK1MAPK1SMN1; SMN2
SCHEMBL8809566 0.89 BCHE (0.43) ABCB1ABCG2OPRK1MAPK1SMN1; SMN2
SCHEMBL8806990 0.89 ABCG2 (0.39) ABCB1ABCG2MAPK1SMN1; SMN2MEN1
SCHEMBL8808101 0.89 BCHE (0.43) ABCB1ABCG2OPRK1MAPK1SMN1; SMN2
SCHEMBL8806941 0.88 ABCG2 (0.40) ABCB1ABCG2MAPK1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663179-A CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS LABORATOIRES GLAXO SA (FR) 1997-09-02 — — US disclosed
EP-0649410-B1 ANILIDE DERIVATIVES GLAXO LAB SA (FR) 1997-05-02 — — EP disclosed
Send feedback